Latest Patent Grant Is Driving VYNE Therapeutics Stock Higher Today

VYNE Therapeutics Inc. (NASDAQ: VYNE) is seeing a significant boost in the price of its stock today. As of the last check during current session, VYNE stock was up 11.11% to $2.50. A notable developments in VYNE’s portfolio of intellectual property is the driving force behind that surge. Announcement of Patent Grant VYNE Therapeutics unveiled […]

VYNE Therapeutics Inc. (VYNE) had a Bearish Spell, Here’s Why

VYNE Therapeutics Inc. (VYNE), a pharmaceutical company, has surged 7.7% in aftermarket trading session and consequently is trading at $0.74 at the time of the writing. On Monday, VYNE closed the day at $0.6871 after plummeting by 12.53% during regular trading hours. The massive slide was attributable to the divestment of topical minocycline assets. Why […]

News IMC
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.